3 min read FDA Moves to End Compounded Semaglutide and Tirzepatide What It Means for Weight Loss Patients The FDA Just Proposed a Major Change to Compounded Weight Loss Drugs If you've been following the news about weight loss medications, you may have heard that the FDA announced a significant regulatory change on April 30, 2026
Side Effects The most common side effects are gastrointestinal symptoms, injection-site reactions, mild flu-like symptoms, and transient headaches
Dado que estos medicamentos son relativamente nuevos, an se desconocen sus efectos a largo plazo , segn los expertos
Standard care begins with 3 months of GLP-1 injections, with dosage adjustments and monitoring via regular check-ins
Encourage patients to: Eat smaller, more frequent meals to reduce nausea Avoid high-fat or heavy foods that can worsen GI symptoms Stay consistently hydrated throughout the day Include fiber-rich foods to support digestion and prevent constipation Prioritize protein intake to help prevent muscle loss 3
doi: 10.1146/annurev-anchem-071114-040343 39 CaoYZhaoFFengPHongYZhangYZhangZet al